Risk factors associated hyphema after intravitreal injection of bevacizumab before trabeculectomy for neovascular glaucoma
Phase 4
Recruiting
- Conditions
- neovascular glaucoma uncontrolled IOPNVGhyphemaintravireal avastin bevacizumab injectiontrabeculectomyNVI
- Registration Number
- TCTR20160826002
- Lead Sponsor
- Chiangmai university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 81
Inclusion Criteria
Neovascular glaucoma patient at least 18 years old
IOP >21mmHg with full medications
multiple medications or side effects with medications
Exclusion Criteria
CVS or CNS disease or poor health status
previous eye surgery
currenly taking anti platelet or anticoagulant unable to stop 7 days before surgery
hyphema before surgery
VA= no light perception
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method risk factor of post trabeculectomy hyphema after intravitreal bevacizumab injection none risk factors
- Secondary Outcome Measures
Name Time Method short-term outcome of trabeculectomy in NVG none outcome